EQ Company Profile and Key Details

Q: Who are the executives of EQ?

Ms. Maple Fung M.D.Chief Medical OfficerDr. Stephen Connelly Ph.D.Chief Scientific Officer & DirectorMr. Jason A. KeyesChief Financial OfficerDr. Krishna R. Polu M.D.ConsultantMr. Daniel Mark BradburyExecutive ChairmanMatthew Ritter Ph.D.Senior Vice President of Corporation Devel.Mr. Bruce D. Steel C.F.A.Co-Founder, Pres, Chief Executive Officer & DirectorMs. Christine Zedelmayer M.B.A., P.M.P.Senior Vice President & Chief Operating OfficerMr. Joel M. RothmanChief Devel. Officer

NASDAQ : EQ

Equillium

$2.31

0.04+1.76%

At Close 4:00 PM

62.42

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Equillium, Inc. (EQ) stock surged +1.76%, trading at $2.31 on NASDAQ, up from the previous close of $2.27. The stock opened at $2.30, fluctuating between $2.24 and $2.46 in the recent session.

Stock Snapshot

2.27

Prev. Close

146.05M

Market Cap

2.24

Day Low

-7.22

P/E Ratio

-0.32

EPS (TTM)

-0.62

Cash Flow per Share

2.3

Open

63.23M

Number of Shares

2.4641

Day High

49.39%

Free Float in %

0.64

Book Value

557.29K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Aug 21, 2026	2.30	2.46	2.24	2.31	557.29K
Aug 20, 2026	2.27	2.33	2.21	2.27	242.24K
Aug 19, 2026	2.43	2.43	2.28	2.33	247.81K
Aug 18, 2026	2.45	2.55	2.32	2.35	710.43K
Aug 17, 2026	2.26	2.49	2.26	2.48	261.49K
Aug 14, 2026	2.03	2.37	1.96	2.36	537.02K
Aug 13, 2026	2.18	2.25	1.98	2.01	542.88K
Aug 12, 2026	2.25	2.29	2.13	2.18	600.09K
Aug 11, 2026	2.19	2.25	2.05	2.23	1.14M
Aug 10, 2026	2.09	2.23	2.02	2.19	630.22K
Aug 07, 2026	2.14	2.17	2.08	2.11	406.23K
Aug 06, 2026	2.18	2.23	2.10	2.12	468.62K
Aug 05, 2026	2.29	2.32	2.17	2.19	322.3K
Aug 04, 2026	2.23	2.32	2.17	2.26	438.57K
Aug 03, 2026	2.19	2.34	2.15	2.20	522.84K
Jul 31, 2026	2.31	2.37	2.17	2.20	729K
Jul 30, 2026	2.29	2.38	2.22	2.32	395.26K
Jul 29, 2026	2.30	2.36	2.18	2.28	380.87K
Jul 28, 2026	2.43	2.48	2.22	2.32	966.52K
Jul 27, 2026	2.51	2.65	2.45	2.46	278.63K

Contact Details

La Jolla, CA 92037

United States

https://equilliumbio.com 858 412 5302

About Company

Equillium, Inc. is a clinical-stage biopharmaceutical company focused on developing and bringing to market products designed to address severe autoimmune and inflammatory (immuno-inflammatory) disorders where current treatment options are insufficient. The company's primary drug candidate is itolizumab (EQ001), a monoclonal antibody in clinical development that targets the novel CD6 immune checkpoint receptor. Itolizumab is currently in Phase III trials for acute graft-versus-host disease, has completed Phase Ib studies for asthma, and is also undergoing Phase Ib trials for lupus nephritis. In addition to itolizumab, Equillium is advancing EQ101 for the treatment of cutaneous T cell lymphoma and alopecia areata, and EQ102, which targets various gastrointestinal conditions. Headquartered in La Jolla, California, the company was incorporated in 2017 and previously operated as Attenuate Biopharmaceuticals, Inc. before changing its name to Equillium, Inc. in May 2017.

Stock Peers

ARGX

1.66+0.16%

argenx SE$1,039.78 REGN

7.4+0.90%

Regeneron Pharmaceuticals, Inc.$834.04 VRTX

7.79+1.44%

Vertex Pharmaceuticals Incorporated$548.05 MDGL

-2.35-0.45%

Madrigal Pharmaceuticals, Inc.$516.74 UTHR

-7.88-1.51%

United Therapeutics Corporation$513.12 PRAX

11.36+3.12%

Praxis Precision Medicines, Inc.$375.94 ONC

5.31+1.44%

BeOne Medicines AG$374.47 KRYS

9.56+2.84%

Krystal Biotech, Inc.$346.58 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

-1.1-0.38%

Ligand Pharmaceuticals Incorporated$286.29

Frequently Asked Questions

What is the current Equillium, Inc. (EQ) stock price?

Equillium, Inc. (NASDAQ: EQ) stock price is $2.31 in the last trading session. During the trading session, EQ stock reached the peak price of $2.46 while $2.24 was the lowest point it dropped to. The percentage change in EQ stock occurred in the recent session was 1.76% while the dollar amount for the price change in EQ stock was $0.04.

EQ's industry and sector of operation?

The NASDAQ listed EQ is part of Biotechnology industry that operates in the broader Healthcare sector. Equillium, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of EQ?

Ms. Maple Fung M.D.
Chief Medical Officer
Dr. Stephen Connelly Ph.D.
Chief Scientific Officer & Director
Mr. Jason A. Keyes
Chief Financial Officer
Dr. Krishna R. Polu M.D.
Consultant
Mr. Daniel Mark Bradbury
Executive Chairman
Matthew Ritter Ph.D.
Senior Vice President of Corporation Devel.
Mr. Bruce D. Steel C.F.A.
Co-Founder, Pres, Chief Executive Officer & Director
Ms. Christine Zedelmayer M.B.A., P.M.P.
Senior Vice President & Chief Operating Officer
Mr. Joel M. Rothman
Chief Devel. Officer

How EQ did perform over past 52-week?

EQ's closing price is 203.95% higher than its 52-week low of $0.76 where as its distance from 52-week high of $3.54 is -34.75%.

How many employees does EQ have?

Number of EQ employees currently stands at 14.

Link for EQ official website?

Official Website of EQ is: https://equilliumbio.com

How do I contact EQ?

EQ could be contacted at phone 858 412 5302 and can also be accessed through its website. EQ operates from 2223 Avenida De La Playa, La Jolla, CA 92037, United States.

How many shares of EQ are traded daily?

EQ stock volume for the day was 557.29K shares. The average number of EQ shares traded daily for last 3 months was 879.22K.

What is the market cap of EQ currently?

The market value of EQ currently stands at $146.05M with its latest stock price at $2.31 and 63.23M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	14
Beta	1.81
Sales or Revenue	$36.08M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	14
Beta	1.81
Sales or Revenue	$36.08M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

EQ Company Profile and Key Details

Equillium

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Dividend & Fair Value

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways